Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for...

Related Keywords

United States ,Ireland ,Dublin ,Irish ,American ,Aaron Palash ,Michael Freitag ,Daniel Speciale ,Joele Frank ,Siggi Olafsson ,Prnewswire Mallinckrodt ,Derek Belz ,Wilkinson Brimmer Katcher ,Exchange Commission ,Us Drug Enforcement Administration ,Mallinckrodt Pharmaceuticals ,Drug Administration ,Company Specialty Brands ,Revenue Service Under Section ,Notification Application ,Next Generation Delivery System ,New Executives ,Ordinary Shares Commenced Trading ,Webcast Today ,Chief Executive ,Specialty Brands ,Specialty Generics ,Investor Relations ,Private Securities Litigation Reform Act ,Internal Revenue Service ,Internal Revenue Code ,Acthar Gel ,Enforcement Administration ,Financial Condition ,Annual Report ,Quarterly Reports ,Corporate Controller ,Chief Investor Relations ,Wilkinson Brimmer ,Chief Executive Officer ,Mallinckrodt Plc ,